The Drugs Controller General of India (DCGI) has given permission for the emergency use of drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderate to severe Covid-19 cases, said Defense Research and Development Organisation on Saturday.
“Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty,” said the DRDO in a statement.
“The drug has been developed by DRDO lab Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories. Clinical trial have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence,” the statement read.
According to DRDO, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints in the efficacy trends.
In recent discussions about health and nutrition, seed oils—derived from sources like sunflower, soybean, corn,…
For anyone, fruits are often the go-to choice for adding vitamins, minerals, and natural antioxidants…
Air Pollution: Do you know how seriously air pollution can affect your health? Recent studies…
Learn how to safely manage Vitamin D supplementation and avoid toxicity with our expert advice.…
Discover how to break your fast with the right foods to enhance digestion and avoid…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…